close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clarivate Plc Ordinary Shares (NY:CLVT)

2.470 -0.170 (-6.44%)
Official Closing Price Updated: 6:30 PM EDT, Jun 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clarivate Plc Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Generative AI Startup AI21 Labs Reaches Unicorn Status With Latest Funding Round ↗
AI21 Labs, a front-runner in the AI domain specializing in large language models (LLMs), declared the completion of a $155 million Series C fundraiser.  
Via Benzinga
Topics Artificial Intelligence
News headline image
Where Clarivate Stands With Analysts ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023 ↗
 
Via Benzinga
News headline image
12 Industrials Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About Clarivate ↗
 
Via Benzinga
News headline image
Where Clarivate Stands With Analysts ↗
 
Via Benzinga
News headline image
Analyst Expectations for Clarivate's Future ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Clarivate ↗
 
Via Benzinga
News headline image
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023 ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2023 ↗
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Expert Ratings for Clarivate ↗
 
Via Benzinga
News headline image
12 Industrials Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts ↗
Oppenheimer analyst Owen Lau initiates coverage on Clarivate Plc (NYSE: CLVT) with an Outperform rating and  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023 ↗
 
Via Benzinga
News headline image
Expert Ratings for Clarivate ↗
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Where Clarivate Stands With Analysts ↗
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Analyst Ratings for Clarivate ↗
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
5 Analysts Have This to Say About Clarivate ↗
Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter: 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 61 companies hit new 52-week lows. 
Via Benzinga
News headline image
12 Industrials Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About Clarivate ↗
  Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter: 
Via Benzinga
News headline image
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
News headline image
Morgan Stanley Maintains Overweight Rating for Clarivate: Here's What You Need To Know ↗
Morgan Stanley has decided to maintain its Overweight rating of Clarivate (NYSE:CLVT) and lower its price target from $16.00 to $15.00. Shares of Clarivate are trading down 2.75% over the last 24... 
Via Benzinga
News headline image
Recap: Clarivate Q2 Earnings ↗
  Clarivate (NYSE:CLVT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Singapore's National Library Board Picks Clarivate's Software Solutions To Support LAB25 Initiative ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today